MENU
CH | CHF
-
-
-
-
- WHX Labs Dubai 2026
- analytica 2026
- Forum Labo 2026
- SLAS Europe 2026
- Forum Labo 2026 Bioprocess
- Bioprocessing Summit Europe 2026
- BioProcess International 2026
- Swiss Biotech Day 2025
- ISCT 2026
- Pichia 2026
- Future Labs Live 2026
- BioProScale Sympposium 2026
- ASGCT 2026
- Eppendorf Automation Forum 2026
- ESACT 2026
- ELRIG Drug Discovery 2026
-
-
-
-
- WHX Labs Dubai 2026
- analytica 2026
- Forum Labo 2026
- SLAS Europe 2026
- Forum Labo 2026 Bioprocess
- Bioprocessing Summit Europe 2026
- BioProcess International 2026
- Swiss Biotech Day 2025
- ISCT 2026
- Pichia 2026
- Future Labs Live 2026
- BioProScale Sympposium 2026
- ASGCT 2026
- Eppendorf Automation Forum 2026
- ESACT 2026
- ELRIG Drug Discovery 2026
CH | CHF
-
- Pipettes, distributeurs et dispositifs de manipulation de liquides automatisée
- Pipettes mécaniques
- Pipettes électroniques
- Pipettes multicanaux
- Pipettes et distributeurs à déplacement positif
- Distributeurs sur flacon
- Auxiliaires de pipetage
- Accessoires pour pipettes et distributeurs
- Pipetage automatisé
- Consommables d’automatisation
- Accessoires d’automatisation
- Services pour pipettes et distributeurs
Sorry, we couldn't find anything on our website containing your search term.
Sorry, we couldn't find anything on our website containing your search term.
- Page d'accueil
- Entreprise et carrières
- Actualités et médias
- Actualités
- Eppendorf signs agreement for new production site in Penang, Malaysia
Eppendorf signs agreement for new production site in Penang, Malaysia
news
- Communiqués de presse
- Nouvelles de l’entreprise
Eppendorf has signed an agreement for a new production site in Penang, Malaysia, marking the start of its planned greenfield manufacturing facility in Bandar Cassia Technology Park. The company is investing EUR 40 million in the site, with production of initial products expected to begin in 2028.
- Agreement marks the start of Eppendorf’s planned manufacturing facility in Penang
- Eppendorf will invest EUR 40 million in the site, with production expected to start in 2028
- New facility will produce selected products of the Centrifuges & Instruments portfolio for global laboratory markets
“Today’s signing marks a significant next step for the Eppendorf Group,” said Dr. Christine Munz, CEO of the Eppendorf Group. “For more than 30 years, Malaysia has been an important part of Eppendorf’s history in the Asia-Pacific region. With the planned new production site in Penang, we are strategically expanding our global manufacturing network and creating a high-performance production platform in Southeast Asia that will sustainably support Eppendorf’s long-term growth.”
The new facility will manufacture selected products from Eppendorf’s Centrifuges & Instruments portfolio. Eppendorf expects the site to employ around 130 people by the end of 2029.
Lire la suite
Press Release
PDF 0,43 MB
JPG 3,98 MB